본문으로 건너뛰기
← 뒤로

Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.

1/5 보강
Gastroenterology 2026 Vol.170(2) p. 298-314
Retraction 확인
출처

Plugge SF, Ma H, van der Vaart JY, Sprangers J, Morsink FHM, Xanthakis D, Jamieson C, Stroot KBW, Keijzer AR, Margaritis T, Candelli T, Straver R, de Ridder J, Holstege FCP, de Leng WWJ, Offerhaus GJA, Merenda A, Maurice MM

📝 환자 설명용 한 줄

[BACKGROUND & AIMS] Heterozygous inactivating mutations of Serine Threonine Kinase 11/Liver Kinase B1 (LKB1) are causative to the Peutz-Jeghers syndrome (PJS), a hereditary disease characterized by ga

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Plugge SF, Ma H, et al. (2026). Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.. Gastroenterology, 170(2), 298-314. https://doi.org/10.1053/j.gastro.2025.07.041
MLA Plugge SF, et al.. "Intestinal LKB1 Loss Drives a Premalignant Program Along the Serrated Cancer Pathway.." Gastroenterology, vol. 170, no. 2, 2026, pp. 298-314.
PMID 41128695

Abstract

[BACKGROUND & AIMS] Heterozygous inactivating mutations of Serine Threonine Kinase 11/Liver Kinase B1 (LKB1) are causative to the Peutz-Jeghers syndrome (PJS), a hereditary disease characterized by gastrointestinal hamartomatous polyposis and increased cancer susceptibility. Although LKB1 loss-induced polyp formation has been ascribed to nonepithelial tissues, how LKB1 deficiency increases cancer risk of patients by altering the phenotypical landscape and hierarchical organization of epithelial tissues remains poorly understood.

[METHODS] Using CRISPR/Cas9, we generated heterozygous and homozygous Lkb1-deficient mouse small intestinal and human colon organoids. These organoids were characterized by an integrated approach that combines imaging, bulk and single-cell RNA sequencing, and growth factor dependency assays. Our findings were validated in human PJS-derived tissues using immunohistochemistry and linked to colorectal cancer profiles using the Cancer Genome Atlas (TCGA) cancer database.

[RESULTS] Our results reveal that heterozygous Lkb1 loss is sufficient to push intestinal cells into a premalignant transcriptional program associated with serrated colorectal cancer, which is further amplified by loss of heterozygosity. This altered epithelial growth state associates with persistent features of regeneration and enhanced EGFR ligand and receptor expression, conferring niche-independent growth properties to Lkb1-deficient organoids. Moreover, our newly generated LKB1-mutant signature is enriched in sporadic serrated colorectal cancer, and synergistic cooperation of Lkb1 deficiency with mutant Kras was experimentally confirmed by assessing organoid growth properties and transcriptomes.

[CONCLUSIONS] Heterozygous loss of LKB1 pushes intestinal cells into a chronic regenerative state, which is amplified on loss of heterozygosity. Lkb1 deficiency thereby generates fertile ground for serrated colorectal cancer formation in the intestine, potentially explaining the increased cancer risk observed in PJS.

MeSH Terms

Humans; Protein Serine-Threonine Kinases; Animals; AMP-Activated Protein Kinase Kinases; Peutz-Jeghers Syndrome; Organoids; Colorectal Neoplasms; Mice; Precancerous Conditions; Signal Transduction; ErbB Receptors; Mice, Knockout; Colon; Cell Proliferation; Gene Expression Regulation, Neoplastic; Disease Models, Animal; Proto-Oncogene Proteins p21(ras); Cell Transformation, Neoplastic; Intestinal Mucosa; CRISPR-Cas Systems; AMP-Activated Protein Kinases